Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Pattern Scan Laser System vs Regular Photocoagulation System: Changes in Electroretinograms and Contrast Sensitivity Post Treatment.
Sponsor: Asociación para Evitar la Ceguera en México
Terminated
Undefined
Other terminated trials from Asociación para Evitar la Ceguera en México
- Epiretinal Membrane · Phase PHASE3 · Feb 2014
- Proliferative Diabetic Retinopathy · Phase NA · Mar 2013
- Neovascular Glaucoma · Phase NA · Feb 2013
- Pain · Phase EARLY_PHASE1 · May 2010
- Vitrectomy · May 2010
See all terminations from Asociación para Evitar la Ceguera en México
Other Non Proliferative Diabetic Retinopathy trials with similar outcome
This PHASE4 trial investigates Non Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy and is currently terminated or withdrawn. Asociación para Evitar la Ceguera en México leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated
-
Jan 2021 — Jun 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asociación para Evitar la Ceguera en México
For direct contact, visit the study record on ClinicalTrials.gov .